Related Experiment Videos
E1A sensitizes cells to tumor necrosis factor alpha by downregulating c-FLIP S
1Center for Advanced Biotechnology and Medicine, Department of Molecular Biology and Biochemistry, Rutgers University, 679 Hoes Lane, Piscataway, NJ 08854, USA.
Journal of Virology
|January 29, 2003
Summary
Adenovirus E1A protein sensitizes cells to tumor necrosis factor alpha (TNF-alpha)-induced apoptosis by downregulating c-FLIP. This mechanism offers potential therapeutic strategies for apoptosis-refractory tumors.
Area of Science:
- Molecular Biology
- Cellular Signaling
- Virology
Background:
- Tumor necrosis factor alpha (TNF-alpha) triggers both cell death (apoptosis) and survival pathways.
- c-FLIP is a gene induced by TNF-alpha that normally inhibits apoptosis.
- Apoptosis requires the inhibition of gene expression to proceed.
Purpose of the Study:
- To investigate how adenovirus E1A protein sensitizes cells to TNF-alpha-induced apoptosis.
- To elucidate the role of c-FLIP regulation by E1A in TNF-alpha signaling.
- To explore potential therapeutic targets for overcoming apoptosis resistance in tumors.
Main Methods:
- Studied TNF-alpha-mediated apoptosis and survival signaling in cells with and without E1A expression.
- Assessed caspase-8 activation, c-FLIP(S) expression, and mRNA induction.
- Investigated the effects of c-FLIP(S) and viral FLIP expression on E1A-mediated sensitization.
- Analyzed E1A's impact on c-FLIP(S) mRNA induction and protein degradation via ubiquitination and proteasome pathways.
Main Results:
- E1A expression sensitized cells to TNF-alpha-induced apoptosis by disabling survival pathways.
- E1A promoted caspase-8 activation and downregulated c-FLIP(S) expression, preventing its TNF-alpha induction.
- Restoring c-FLIP(S) or viral FLIP expression rescued cells from E1A-mediated sensitization.
- E1A inhibited c-FLIP(S) mRNA induction and enhanced its proteasomal degradation.
Conclusions:
- Adenovirus E1A sensitizes cells to TNF-alpha by interfering with c-FLIP-mediated inhibition of apoptosis.
- E1A disrupts the NF-kappaB pathway's induction of c-FLIP and promotes its degradation.
- Targeting c-FLIP regulation, specifically inhibiting its induction and promoting its degradation, presents a novel therapeutic strategy for eliminating apoptosis-resistant cancer cells.